Answers are grounded in this paper and cite their sources.
Introduction: Hepatocellular carcinoma (HCC) progression is closely to inflammatory pathways, with tumor necrosis factor-alpha (TNF-α) recognized as a central mediator. This study aimed to examine the association between serum TNF-α concentrations and the clinical severity of HCC, as well as to evaluate its predictive value for short-term mortality. Methods: A prospective cohort study was conducted from January 2024 to December 2024, involving 76 HCC patients recruited through total sampling methods. Baseline TNF-α levels were measured, and participants were followed for 6 months to assess survival outcomes. Statistical analyses included Chi-square test, Fisher’s exact test, independent t -test, Mann–Whitney U -test, and binary logistic regression, with a significance defined as P < 0.05. Results: The mean TNF-α level was 46.96 ± 18.54 pg/mL, with survivors and nonsurvivors showing levels of 45.51 ± 19.91 pg/mL and 48.85 ± 16.7 pg/mL, respectively ( Z = −1.473; P = 0.141). TNF-α levels were dichotomized using a receiver operating characteristic-derived cutoff of 44.76 pg/mL. Elevated TNF-α levels were significantly associated with HCC mortality (odds ratio [OR] = 0.306; P = 0.013), supported by bivariate (OR = 3.267; 95% confidence interval [CI] = 1.267–8.419; P = 0.012) and multivariate (OR = 0.153; 95% CI = 0.040–0.591; P = 0.006). Additional predictors included Child–Pugh score and hepatitis B status. Conclusions: Although TNF-α was not an independent predictor, its significant correlation with disease severity and mortality underscores its potential utility in prognostic stratification for HCC.
No takes yet. Share an insight, caveat, or question.
Fatmawati et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: